Maryland Academy of Advanced Practice Clinicians

Register now for Pharmacology Update 2020: Webinar & Kick-off Zoom Meeting. Why? We can’t know enough about COVID-19

Posted 30 days ago by Elaine Crain

Dr. Shyam Kottilil MD. Ph.D. is the Director of the division of Clinical Care and Research at the Institute of Human Virology (IHV), University of Maryland, Baltimore MD. He is also the Chief of the Division of Infectious Diseases at the University of Maryland School of Medicine, Baltimore MD. Dr. Kottilil continues to work as the Scientific Director of the NIH-District of Columbia Program for AIDS Progress.

 He received his medical degree from Govt Medical College, Trichur, India, Ph.D (immunology of HIV infection) from Memorial University of Newfoundland, Canada, completed a residency in Internal Medicine from Brown University, Rhode Island and a fellowship in infectious diseases rom the National Institutes of Health under Dr. Anthony S. Fauci. 

He has conducted several pivotal investigator-initiated studies in hepatitis C and has authored over 300 peer-reviewed publications. Dr. Kottilil serves as one of the founding members of the US National hepatitis C treatment guidance panel.

 

Don't forget to register for our October 3rd Zoom Kickoff meeting at 10am EST -attending the meeting is free but please add the Attend Kickoff meeting option when registering

Registration is open and webinar will go live on October 3, 2020

Available from Saturday, October 3, 2020 through October 2, 2021

 

Nidhi Kotwal, MD – Childhood Asthma: An Update

Kyleen Davis, CRNP - Skin Cancer: A Review for Clinicians

Mehrnaz Pajoumand, PharmD - Pharmacotherapy of Parkinson Disease

Michael Armahizer, PharmD – Acute Ischemic Stroke Pharmacotherapy in 2020

Aaron Rapopor, MD - Cellular Immunotherapy in Blood Cancers

Shyamasundaran Kottilil, MD - Pharmacologic Treatment of COVID 19

Mary Banoub, PharmD - Principles of Antimicrobial Therapy in the Hospitalized Patient

This education activity has been submitted to the American Association of Nurse Practitioners for approval of 7.0 contact hours of continuing education (which includes 6.6 hours pharmacology).

  

We are also proud to welcome back our Industry and Pharmaceutical partners with the construction of a virtual exhibit hall Stay tuned! 

Questions? Contact Lorraine Diana & Gena Stanek at TheMAAPC@gmail.com